LifeScience Weekly Digest: Key Industry Updates (6th – 10th January)
In early 2025, significant developments across the biopharmaceutical and medical device sectors...
Read More
Category: News
Regulatory Roundup: Weekly Insights on Pharma and MedTech—Key Updates from Leading Agencies (December 30th to January 3rd)
Welcome to this week’s Regulatory Insights from Synopulse, featuring the latest updates from the...
Read More
Transcarent paying $621M to acquire health benefits navigator Accolade
Transcarent has announced plans to acquire Accolade for $621 million, marking a significant step...
Read MorePfizer picks Triana Biomedicines to find Molecular Glues for Cancer
US pharmaceutical giant Pfizer announced a groundbreaking collaboration with Triana Biomedicines to develop Molecular Glue Degraders. The partnership aims to create multiple advanced therapies, including cancer. The...
Read MoreOncoC4 merged with AcroImmune
An all-stock transaction between OncoC4, a biopharmaceutical business in its late stages, and AcroImmune has been completed. OncoC4 strengthens its development by adding two critical drug candidates, AI-061, a PD-1/VEGF...
Read More